COVIDSafe: New app to slow the spread of the coronavirus
26 April 2020 The Australian Government today launches the new voluntary coronavirus app, COVIDSafe. The app is an important public health initiative that will help keep you, your family, and your community safe from further spread of coronavirus…
Jobkeeper update
24 April 2020 The Morrison Government’s historic $130 billion JobKeeper payment will support millions of Australian jobs and help cushion the blow from the severe economic impact from the coronavirus. The $1,500 per fortnight JobKeeper payment is the…
COVID-19: rapid response boost for Australia’s intensive care units
23 April 2020 Ensuring Australian hospitals are able to respond rapidly in the event of increased patient demand during the COVID-19 health emergency is a national priority. Minister for Health, Greg Hunt, announced the Australian Government has funded…
Trials begin for a new type of face mask
22 April 2020 RMIT fashion and textiles experts have designed a new style of protective face mask for healthcare workers. The staff and student team has sewn 100 of the prototype masks as part of a Federal Government…
Immutep completes enrollment for INSIGHT-004 study
23 April 2020 Immutep Limited, a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announced that the last patient has been enrolled and safely dosed for the second cohort of the INSIGHT-004 Phase I clinical…
PolyNovo first Canadian BTM use
23 April 2020 PolyNovo is pleased to announce the first use of NovoSorb BTM in Canada. This case was initiated by one of Canada’s leading surgeons who is a key opinion leader in this field. PolyNovo has not…
NovoSorb® BTM Feasibility Study Results for US FDA
21 April 2020 PolyNovo is pleased to share the summary of results for the CP-002 Feasibility Study to assess the safety and effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the treatment of severe skin burn injuries. This…
Gilead, Kite and oNKo-innate announce research collaboration
23 April 2020 Gilead Sciences, Inc. (Nasdaq: GILD), Kite, a Gilead Company, and oNKo-innate announced the companies have entered into a three-year cancer immunotherapy research collaboration to support discovery and development of next-generation drug and engineered cell therapies…
VivaZome Therapeutics Pty Ltd and ToolGen, Inc. extend collaboration agreement based on successful proof-of-concept outcomes
22 April 2020 Melbourne, Australia and Seoul, South Korea: VivaZome Therapeutics Pty Ltd (“VivaZome”) and ToolGen, Inc (“ToolGen”) have announced the extension of a collaborative research project exploring the gene-editing of cells for enhanced exosome production. Under the…
Bosch Australia’s Manufacturing Solutions business unit awarded COVID-19 project by Grey Innovation
21 April 2020 Bosch Australia’s Manufacturing Solutions division (BAMS) has been awarded a AUD $1 million project as part of the industry consortium to build ventilators in Victoria. The notus Emergency Invasive Ventilator Program, a Grey Innovation led…
Clinical trial into two potential COVID-19 treatments commences
21 April 2020 A clinical trial aimed at testing the effectiveness and safety of two existing drugs in patients hospitalised with COVID-19 has opened at the first site, The Royal Melbourne Hospital. Led by Associate Professor Steven Tong, a Royal…
Victoria’s coronavirus (COVID-19) modelling confirms staying at home saves lives
20 April 2020 The Victorian Government has released modelling to provide greater understanding of the spread of coronavirus in Victoria. The modelling, done by Victoria’s epidemiological experts at the Department of Health and Human Services and in collaboration…
